CRL
Charles River Laboratories
Charles River Laboratories 13F Holders
CRL Stock Ownership Activity
- # of activities:
- 3
- AVG reported price*:
- $195.98
- Current price*:
- +16.97%($229.24)
3 value investing gurus have made changes to the Charles River Laboratories (CRL) position according to the gurus' 2023 Q3 SEC quarterly report(s). CRL has been bought (as a new position) by 1 guru(s), the number of CRL shares has been increased by 2 super investor(s).
Which gurus or hedge funds bought CRL in 2023 Q3?
According to the 2023 Q3 SEC filing(s) Charles River Laboratories (CRL) has been bought by 3 gurus / funds: Nathaniel Simons - Meritage Group (new buy), Eric H. Schoenstein - Jensen Investment Management (added shares +2.20%) and Polen Capital Management (added shares +1.01%).
To see more about who is investing in Charles River Laboratories (CRL), please go to the CRL ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.